CGH
NVS icon

Crossmark Global Holdings’s Novartis NVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.52M Sell
37,363
-1,306
-3% -$158K 0.07% 264
2025
Q1
$4.31M Buy
38,669
+442
+1% +$49.3K 0.08% 253
2024
Q4
$3.72M Buy
38,227
+2,610
+7% +$254K 0.07% 279
2024
Q3
$4.1M Buy
35,617
+7,824
+28% +$900K 0.07% 270
2024
Q2
$2.96M Buy
27,793
+349
+1% +$37.2K 0.06% 311
2024
Q1
$2.66M Sell
27,444
-378
-1% -$36.6K 0.05% 347
2023
Q4
$2.81M Buy
27,822
+398
+1% +$40.2K 0.06% 322
2023
Q3
$2.7M Sell
27,424
-3,861
-12% -$380K 0.06% 314
2023
Q2
$3.26M Buy
31,285
+1,207
+4% +$126K 0.07% 299
2023
Q1
$2.77M Buy
30,078
+466
+2% +$42.9K 0.07% 322
2022
Q4
$2.69M Sell
29,612
-111
-0.4% -$10.1K 0.07% 318
2022
Q3
$2.26M Buy
29,723
+4,233
+17% +$322K 0.06% 321
2022
Q2
$2.16M Sell
25,490
-1,240
-5% -$105K 0.06% 359
2022
Q1
$2.35M Buy
26,730
+1,690
+7% +$148K 0.05% 364
2021
Q4
$2.19M Buy
25,040
+30
+0.1% +$2.62K 0.05% 382
2021
Q3
$2.05M Sell
25,010
-28,820
-54% -$2.36M 0.05% 378
2021
Q2
$4.91M Sell
53,830
-12,850
-19% -$1.17M 0.12% 187
2021
Q1
$5.7M Sell
66,680
-12,706
-16% -$1.09M 0.14% 166
2020
Q4
$7.5M Buy
79,386
+604
+0.8% +$57K 0.19% 133
2020
Q3
$6.85M Buy
78,782
+15,560
+25% +$1.35M 0.19% 135
2020
Q2
$5.52M Sell
63,222
-30,953
-33% -$2.7M 0.16% 145
2020
Q1
$7.77M Sell
94,175
-5,146
-5% -$424K 0.28% 98
2019
Q4
$9.41M Buy
99,321
+23,182
+30% +$2.2M 0.26% 104
2019
Q3
$6.62M Sell
76,139
-27,955
-27% -$2.43M 0.19% 132
2019
Q2
$9.51M Sell
104,094
-9,705
-9% -$886K 0.27% 94
2019
Q1
$10.9M Buy
113,799
+2,480
+2% +$238K 0.31% 74
2018
Q4
$9.55M Sell
111,319
-610
-0.5% -$52.3K 0.3% 79
2018
Q3
$9.64M Buy
111,929
+24,246
+28% +$2.09M 0.24% 99
2018
Q2
$6.62M Sell
87,683
-56,689
-39% -$4.28M 0.18% 135
2018
Q1
$11.7M Buy
144,372
+12,778
+10% +$1.03M 0.3% 68
2017
Q4
$11M Sell
131,594
-14,696
-10% -$1.23M 0.27% 86
2017
Q3
$12.6M Buy
+146,290
New +$12.6M 0.32% 64
2016
Q3
$12.6M Buy
+146,290
New +$12.6M 0.32% 64